An analysis conducted within the ESTHER cohort, a German population-based study of older individuals living in the community, revealed a substantial early association (spanning between 9 and 17 years prior to clinical diagnosis) of plasma GFAP with the incidence of AD. This evidence concerns the gene GFAP and Alzheimer disease.